CompaniesIons Pharma

Ions Pharma

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (10)
View all

Total Trials

10

As Lead Sponsor

9

As Collaborator

1

Total Enrollment

25,163

By Phase

PHASE2: 1PHASE3: 5PHASE4: 2PHASE1: 2

By Status

COMPLETED: 5RECRUITING: 2NOT_YET_RECRUITING: 1TERMINATED: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT04024163
NCT03945513
NCT05303636
NCT05461573
Hover over trial bars to see details

Recent Trials

NCT06968481Lead Sponsor
Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage
PHASE2Not yet recruiting
330 participants
Started: Oct 1, 2025 · Completed: Apr 30, 2026
NCT06282315Lead Sponsor
Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness
PHASE3Recruiting
20,000 participants
Started: Sep 1, 2025 · Completed: Feb 28, 2027
NCT05461573Lead Sponsor
Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females
PHASE3Completed
1,542 participants
Started: Aug 2, 2022 · Completed: May 27, 2025
NCT05303636Lead Sponsor
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
PHASE4Recruiting
1,710 participants
Started: Mar 28, 2022 · Completed: Mar 31, 2027
NCT05993143Lead Sponsor
Ivermectin to Prevent SARS-CoV-2 (COVID-19) Hospitalisation in Subjects Over 50
PHASE3Terminated
249 participants
Started: Jan 18, 2021 · Completed: Jul 21, 2021
View all 10 trials →
Ions Pharma | Biotech Hunter | Biotech Hunter